These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression of costimulatory and inhibitory receptors in FoxP3 Toker A; Ohashi PS Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899 [TBL] [Abstract][Full Text] [Related]
24. The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Sebio A; Wilky BA; Keedy VL; Jones RL Future Oncol; 2018 May; 14(12):1197-1211. PubMed ID: 29699407 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642 [TBL] [Abstract][Full Text] [Related]
26. Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma. Siefker-Radtke AO; Apolo AB; Bivalacqua TJ; Spiess PE; Black PC J Urol; 2018 May; 199(5):1129-1142. PubMed ID: 29113841 [TBL] [Abstract][Full Text] [Related]
27. Current developments in immunotherapy in the treatment of multiple myeloma. Köhler M; Greil C; Hudecek M; Lonial S; Raje N; Wäsch R; Engelhardt M Cancer; 2018 May; 124(10):2075-2085. PubMed ID: 29409124 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy for kidney cancer: status quo and the future. Bedke J; Stühler V; Stenzl A; Brehmer B Curr Opin Urol; 2018 Jan; 28(1):8-14. PubMed ID: 29120911 [TBL] [Abstract][Full Text] [Related]
29. Drug resistance and new therapies in colorectal cancer. Van der Jeught K; Xu HC; Li YJ; Lu XB; Ji G World J Gastroenterol; 2018 Sep; 24(34):3834-3848. PubMed ID: 30228778 [TBL] [Abstract][Full Text] [Related]
30. Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative Strategies. Moehler M; Göpfert K; Lenz HJ Oncol Res Treat; 2018; 41(5):313-315. PubMed ID: 29705792 [TBL] [Abstract][Full Text] [Related]
31. Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from Hype. Moehler M Oncol Res Treat; 2018; 41(5):264-265. PubMed ID: 29705785 [No Abstract] [Full Text] [Related]
32. Immune resilience in response to cancer therapy. Gicobi JK; Barham W; Dong H Cancer Immunol Immunother; 2020 Nov; 69(11):2165-2167. PubMed ID: 33011909 [No Abstract] [Full Text] [Related]
34. Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy. Park SY; Kim IS Cancer Lett; 2019 Jun; 452():51-58. PubMed ID: 30910590 [TBL] [Abstract][Full Text] [Related]
35. Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? Goedegebuure RSA; de Klerk LK; Bass AJ; Derks S; Thijssen VLJL Front Immunol; 2018; 9():3107. PubMed ID: 30692993 [TBL] [Abstract][Full Text] [Related]
36. Immunological combination treatment holds the key to improving survival in pancreatic cancer. Sodergren MH; Mangal N; Wasan H; Sadanandam A; Balachandran VP; Jiao LR; Habib N J Cancer Res Clin Oncol; 2020 Nov; 146(11):2897-2911. PubMed ID: 32748119 [TBL] [Abstract][Full Text] [Related]
37. Immunotherapy of Hepatocellular Carcinoma. Heinrich B; Czauderna C; Marquardt JU Oncol Res Treat; 2018; 41(5):292-297. PubMed ID: 29705790 [TBL] [Abstract][Full Text] [Related]
38. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy. Amedei A; Niccolai E; Prisco D Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688 [TBL] [Abstract][Full Text] [Related]